Not until a made-in-China mRNA vaccine: Alidad Tash

Alidad Tash estimates Macau’s 2023 GGR to reach about 40 percent of 2019 levels and that we won’t be getting out of a covid zero policy well into the second quarter of next year – once a Made-in-China mRNA has been approved, and administered to the vast majority of the Mainland’s population.

In a special edition of AGB’s Face-to-Face sessions the managing director of 2NT8 goes over some of the questions on the industry’s minds: Genting, Covid-zero, digital currency, next year’s GGR outlook.